Andy Kaempf

6PUBLICATIONS
87CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

|Nov 24, 2025
A Rapid Gene Expression Profiler Classifies AML Tumor Responsiveness to Standard Therapies.

Stephen E Kurtz, Christopher A Eide, Andy Kaempf

|May 21, 2025
Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study.

Curtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena

|Dec 15, 2023
Role of platelet count in a murine stasis model of deep vein thrombosis.

Rick Mathews, Naly Setthavongsack, Anh Le-Cook

|Sep 12, 2023
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.

Christopher A Eide, Stephen E Kurtz, Andy Kaempf

|Mar 22, 2023
Real-World Evaluation of Disease Progression After CDK 4/6 Inhibitor Therapy in Patients With Hormone Receptor-Positive Metastatic Breast Cancer.

Malinda T West, Shaun M Goodyear, Evthokia A Hobbs

Pageof 1

Frequent Collaborators

3 joint publications

Curtis A Lachowiez

3 joint publications

Jeffrey W Tyner

3 joint publications

Jennifer N Saultz

3 joint publications

Christopher A Eide